Cadre Holdings Inc

CDRE is in a Stage 3 distribution phase with bearish control below its key moving averages and no reversal patterns in sight. The recent decisive breakdown through the $30.75–$31.00 support zone under declining EMAs confirms continuation bias, favoring immediate selling into current weakness.

• ↑Q2’26 net sales reached $207.1 M, up 32% YoY and 16% above estimates.
• ↑Adjusted EBITDA grew 56% to $42 M, driven by recurring demand.
• ↓Q2’26 profit margin fell to 5.5% from 7.8%, signaling margin pressure.